mp:Vdraft Sandbox: verschil tussen versies

Uit informatiestandaarden
Naar navigatie springen Naar zoeken springen
← Oudere bewerking
Wetering (overleg | bijdragen)
Write
3.043 bewerkingen
Geen bewerkingssamenvatting
Wetering (overleg | bijdragen)
Write
3.043 bewerkingen
Geen bewerkingssamenvatting
 
(209 tussenliggende versies door 2 gebruikers niet weergegeven)
Regel 1: Regel 1:
{{anchor|tabel1}}
{| class="wikitable" "cellpadding="10"
|+Tabel 1. Overzicht situaties specifieke en generieke MBH-id voor EVS en AIS
|-
! style="text-align:left;"|Situatie
! style="text-align:left;"|EVS
! style="text-align:left;"|AIS
! style="text-align:left;"|ETDR
|-
! style="text-align:left;"|Migreren van actuele en recent gestopte medicatie
| style="background-color: white;vertical-align:top;"|Specifieke MBH-id||Generieke MBH-id
| style="background-color: white;vertical-align:top;"|Generieke MBH-id
|-
! style="text-align:left;"|Migreren van historische medicatie
| style="background-color: white;vertical-align:top;"|Generieke MBH-id||Generieke MBH-id
| style="background-color: white;vertical-align:top;"|Generieke MBH-id
|-
! style="text-align:left;"|Starten van nieuwe MBH
| style="background-color: white;vertical-align:top;"|Specieke MBH-id||Generieke MBH-id<ref>AIS initieert in principe géén specifieke MBH-id. Alleen wanneer er geen PRK is, maakt het AIS een specifieke MBH-id aan (zie paragraaf [[#Bijzondere situaties|Bijzondere situaties]]).</ref>
| style="background-color: white;vertical-align:top;"|Generieke MBH-id


__NUMBEREDHEADINGS__
|-
[[Bestand:Nictiz_logo_PO_rechts_rgb.png |link=https://www.nictiz.nl/|rechts|Naar nictiz.nl]]
 
=Addenda voor inhoudelijke gegevens=
===Patiënt I. XXX_Jangi===
<section begin=XXX_Jangi />
{| class="wikitable" width="85%"
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;"  colspan="4" | Patiënt
|-style="background-color: #1F497D;; color: white; text-align:left;"
|colspan="3" width="25%"| Gegevenselement
|| Waarde
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Naamgegevens
|style="background-color: white;"|I. XXX_Jangi
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Adresgegevens
|style="background-color: white;"|Knolweg 1002 9999ZZ Stitswerd 3 Woon-/verblijfadres
|-style="vertical-align:top; background-color: #E3E3E3;;" 
|colspan="4"|Telefoonnummers
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="3"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Telefoonnummer
|style="background-color: white;"|+31612345678
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Nummer soort
|style="background-color: white;"|Telefoonnummer thuis (code = 'HP' in codeSystem 'HL7 AddressUse')
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Identificatienummer
|style="background-color: white;"|999911727 [BSN]
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Identificatienummer
|style="background-color: white;"|10009 met root OID '2.16.840.1.113883.2.4.3.11.999.77.19829.1'
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Geboortedatum
|style="background-color: white;"|2 aug 1964
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Geslacht
|style="background-color: white;"|Man (code = 'M' in codeSystem 'HL7 AdministrativeGender')
|}<section end=XXX_Jangi /><section begin=DG_XXX_Jangi />
====Documentgegevens XXX_Jangi ====
 
{| class="wikitable" width="85%"
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;"  colspan="5" | Documentgegevens
|-style="background-color: #1F497D;; color: white; text-align:left;"
|colspan="4" width="25%"| Gegevenselement
|| Waarde
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Document datum
|style="background-color: white;"|T
|-style="vertical-align:top; background-color: #E3E3E3;;" 
|colspan="5"|Auteur - zorgaanbieder
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="11"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Organisatie naam
|style="background-color: white;"|Apotheek de Gulle Gaper
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Adresgegevens
|style="background-color: white;"|Zalfstraat 6 1235BB Ons Dorp 5 Werkadres
|-style="vertical-align:top; background-color: #E3E3E3;;" 
|colspan="4"|Telefoonnummers
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="3"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Telefoonnummer
|style="background-color: white;"|+31703655424
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Nummer soort
|style="background-color: white;"|Zakelijk telefoonnummer (code = 'WP' in codeSystem 'HL7 AddressUse')
|-style="vertical-align:top; background-color: #E3E3E3;;" 
|colspan="4"|Email adressen
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="3"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Email adres
|style="background-color: white;"|info@apotheekgullegaper.com
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Email soort
|style="background-color: white;"|Zakelijk e-mailadres (code = 'WP' in codeSystem 'HL7 AddressUse')
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Verificatie patient
|style="background-color: white;"|Nee
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Verificatie zorgverlener
|style="background-color: white;"|Nee
|}<section end=DG_XXX_Jangi /><section begin=MBHS_XXX_Jangi /><section begin=MBH_MBH_MO_123_1 />
 
====Medicamenteuze behandeling MBH_MO_123_1 ====
 
{| class="wikitable" width="85%"
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;"  colspan="5" | Medicatie gebruik
|-style="background-color: #1F497D;; color: white; text-align:left;"
|colspan="4" width="25%"| Gegevenselement
|| Waarde
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Identificatie
|style="background-color: white;"|MBH_MO_123_1_MGB_1 (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.6.1)
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Registratiedatum
|style="background-color: white;"|T, om 10:57
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Gebruik indicator
|style="background-color: white;"|Ja
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Gebruiksperiode
|style="background-color: white;"|Vanaf T- 3 dagen, gedurende 3 dagen
|-style="vertical-align:top; background-color: #E3E3E3;;" 
|colspan="5"|Geneesmiddel - Product specificatie
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="2"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Product naam
|style="background-color: white;"|Ibuprofen
|-style="vertical-align:top; background-color: #E3E3E3;;" 
|colspan="5"|Gebruiksinstructie
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="4"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Omschrijving
|style="background-color: white;"|Vanaf T- 3 dagen, gedurende 3 dagen, 4 maal per dag 1 tablet, oraal
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Toedieningsweg
|style="background-color: white;"|oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen (tabel 7)')
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Doseerinstructie
|style="background-color: white;"|4 maal per dag 1 stuk
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Auteur
|style="background-color: white;"|Patiënt
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Kopie indicator
|style="background-color: white;"|Ja
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Toelichting
|style="background-color: white;"|Pijn
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|MBH identificatie
|style="background-color: white;"|MBH_MO_123_1 (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1)
|}<section end=MBH_MBH_MO_123_1 /><section begin=MBH_MBH_MO_123_2 />
====Medicamenteuze behandeling MBH_MO_123_2 ====
 
{| class="wikitable" width="85%"
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;"  colspan="6" | Toedieningsafspraak
|-style="background-color: #1F497D;; color: white; text-align:left;"
|colspan="5" width="25%"| Gegevenselement
|| Waarde
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="5"|Identificatie
|style="background-color: white;"|MBH_MO_123_2_TA_1 (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.422037009.1)
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="5"|Afspraakdatum
|style="background-color: white;"|T- 6 dagen, om 11:55
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="5"|Gebruiksperiode
|style="background-color: white;"|Vanaf T- 6 dagen, tot nader order
|-style="vertical-align:top; background-color: #E3E3E3;;" 
|colspan="6"|Verstrekker
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="5"|
|-style="vertical-align:top; background-color: #E3E3E3;;" 
|colspan="5"|Zorgaanbieder
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="3"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Zorgaanbieder identificatie nummer
|style="background-color: white;"|01236578 (in identificerend systeem: URA)
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Organisatie naam
|style="background-color: white;"|Apotheek De Gulle Gaper
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="5"|Geneesmiddel - primaire code
|style="background-color: white;"|Emovate zalf 0,5 mg/g (code = '400629' in codeSystem 'G-Standaard HPK')
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="5"|Geneesmiddel - generiekere code
|style="background-color: white;"|CLOBETASON ZALF 0,5MG/G (code = '65617' in codeSystem 'G-Standaard PRK')
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="5"|Geneesmiddel - generiekere code
|style="background-color: white;"|CLOBETASON ZALF 0,5MG/G (code = '115606' in codeSystem 'G-Standaard GPK')
|-style="vertical-align:top; background-color: #E3E3E3;;" 
|colspan="6"|Gebruiksinstructie
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="6"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Omschrijving
|style="background-color: white;"|Vanaf T- 6 dagen, tot nader order, eerst 2 maal per dag zalf gedurende 7 dagen, daarna 1 maal per dag zalf gedurende 7 dagen, daarna 3 maal per week zalf gedurende 7 dagen, cutaan
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Toedieningsweg
|style="background-color: white;"|cutaan (code = '53' in codeSystem 'G-Standaard Toedieningswegen (tabel 7)')
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Doseerinstructie 1
|style="background-color: white;"|eerst gedurende 7 dagen 2 maal per dag
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Doseerinstructie 2
|style="background-color: white;"|dan gedurende 7 dagen 1 maal per dag
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Doseerinstructie 3
|style="background-color: white;"|dan gedurende 7 dagen 3 maal per week
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="5"|Toelichting
|style="background-color: white;"|Eczeem oogleden
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="5"|MBH identificatie
|style="background-color: white;"|MBH_MO_123_2 (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1)
|}<section end=MBH_MBH_MO_123_2 /><section begin=MBH_MBH_MO_123_3 />
====Medicamenteuze behandeling MBH_MO_123_3 ====
 
{| class="wikitable" width="85%"
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;"  colspan="7" | Medicatieafspraak
|-style="background-color: #1F497D;; color: white; text-align:left;"
|colspan="6" width="25%"| Gegevenselement
|| Waarde
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="6"|Identificatie
|style="background-color: white;"|MBH_MO_123_3_MA_1 (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1)
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="6"|Afspraakdatum
|style="background-color: white;"|T- 15 dagen, om 09:13
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="6"|Gebruiksperiode
|style="background-color: white;"|Vanaf T- 15 dagen, gedurende 4 weken
|-style="vertical-align:top; background-color: #E3E3E3;;" 
|colspan="7"|Voorschrijver
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="10"|
|-style="vertical-align:top; background-color: #E3E3E3;;" 
|colspan="6"|Zorgverlener
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="8"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Naamgegevens
|style="background-color: white;"|John de  Vries
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Specialisme
|style="background-color: white;"|Huisartsen, niet nader gespecificeerd (code = '0100' in codeSystem 'COD016-VEKT (Vektis Zorgverlenersspecificatie (subberoepsgroep))')
|-style="vertical-align:top; background-color: #E3E3E3;;" 
|colspan="5"|Zorgaanbieder
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="4"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Zorgaanbieder identificatienummer
|style="background-color: white;"|00001111 (in identificerend systeem: URA)
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Organisatie naam
|style="background-color: white;"|Huisartsenpraktijk Pulver & Partners
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Adresgegevens
|style="background-color: white;"|Werkadres: Dorpsstraat 1 1234AA Ons Dorp
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="6"|Geneesmiddel - primaire code
|style="background-color: white;"|GLIMEPIRIDE TABLET 3MG (code = '44458' in codeSystem 'G-Standaard PRK')
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="6"|Geneesmiddel - generiekere code
|style="background-color: white;"|GLIMEPIRIDE TABLET 3MG (code = '98345' in codeSystem 'G-Standaard GPK')
|-style="vertical-align:top; background-color: #E3E3E3;;" 
|colspan="7"|Gebruiksinstructie
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="4"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="5"|Omschrijving
|style="background-color: white;"|Vanaf T- 15 dagen, gedurende 4 weken, 1 maal per dag 2 tabletten, oraal
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="5"|Toedieningsweg
|style="background-color: white;"|oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen (tabel 7)')
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="5"|Doseerinstructie
|style="background-color: white;"|1 maal per dag 2 stuks
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="6"|Kopie indicator
|style="background-color: white;"|Ja
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="6"|Toelichting
|style="background-color: white;"|Exact 4 weken
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="6"|MBH identificatie
|style="background-color: white;"|MBH_MO_123_3 (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1)
|}
{| class="wikitable" width="85%"
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;"  colspan="6" | Toedieningsafspraak
|-style="background-color: #1F497D;; color: white; text-align:left;"
|colspan="5" width="25%"| Gegevenselement
|| Waarde
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="5"|Identificatie
|style="background-color: white;"|MBH_MO_123_3_TA_1 (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.422037009.1)
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="5"|Afspraakdatum
|style="background-color: white;"|T- 14 dagen, om 15:55
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="5"|Gebruiksperiode
|style="background-color: white;"|Vanaf T- 14 dagen, tot en met T+ 13 dagen, om 23:59
|-style="vertical-align:top; background-color: #E3E3E3;;" 
|colspan="6"|Verstrekker
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="5"|
|-style="vertical-align:top; background-color: #E3E3E3;;" 
|colspan="5"|Zorgaanbieder
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="3"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Zorgaanbieder identificatie nummer
|style="background-color: white;"|01236578 (in identificerend systeem: URA)
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Organisatie naam
|style="background-color: white;"|Apotheek De Gulle Gaper
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="5"|Geneesmiddel - primaire code
|style="background-color: white;"|Glimepiride activis tablet 3mg (code = '1753029' in codeSystem 'G-Standaard HPK')
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="5"|Geneesmiddel - generiekere code
|style="background-color: white;"|GLIMEPIRIDE TABLET 3MG (code = '44458' in codeSystem 'G-Standaard PRK')
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="5"|Geneesmiddel - generiekere code
|style="background-color: white;"|GLIMEPIRIDE TABLET 3MG (code = '98345' in codeSystem 'G-Standaard GPK')
|-style="vertical-align:top; background-color: #E3E3E3;;" 
|colspan="6"|Gebruiksinstructie
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="4"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Omschrijving
|style="background-color: white;"|Vanaf T- 14 dagen, tot en met T+ 13 dagen, om 23:59, 1 maal per dag 2 tabletten, oraal
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Toedieningsweg
|style="background-color: white;"|oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen (tabel 7)')
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Doseerinstructie
|style="background-color: white;"|1 maal per dag 2 stuks
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="5"|Relatie naar medicatieafspraak
|style="background-color: white;"|MBH_MO_123_3_MA_1
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="5"|MBH identificatie
|style="background-color: white;"|MBH_MO_123_3 (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1)
|}
{| class="wikitable" width="85%"
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;"  colspan="5" | Medicatie gebruik
|-style="background-color: #1F497D;; color: white; text-align:left;"
|colspan="4" width="25%"| Gegevenselement
|| Waarde
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Identificatie
|style="background-color: white;"|MBH_MO_123_3_MGB_1 (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.6.1)
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Registratiedatum
|style="background-color: white;"|T, om 12:58
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Gebruik indicator
|style="background-color: white;"|Ja
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Gebruiksperiode
|style="background-color: white;"|Vanaf T- 10 dagen, tot en met T+ 1 dag, om 23:59
|-style="vertical-align:top; background-color: #E3E3E3;;" 
|colspan="5"|Geneesmiddel - Product specificatie
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="2"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Product naam
|style="background-color: white;"|Glimepiride
|-style="vertical-align:top; background-color: #E3E3E3;;" 
|colspan="5"|Gebruiksinstructie
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="3"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Omschrijving
|style="background-color: white;"|Vanaf T- 10 dagen, tot en met T+ 1 dag, om 23:59, 1 maal per dag 1 tablet
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Doseerinstructie
|style="background-color: white;"|1 maal per dag 1 stuk
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Auteur
|style="background-color: white;"|Patiënt
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Kopie indicator
|style="background-color: white;"|Ja
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|MBH identificatie
|style="background-color: white;"|MBH_MO_123_3 (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1)
|}<section end=MBH_MBH_MO_123_3 /><section begin=MBH_MBH_MO_123_4 />
====Medicamenteuze behandeling MBH_MO_123_4 ====
 
{| class="wikitable" width="85%"
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;"  colspan="7" | Medicatieafspraak
|-style="background-color: #1F497D;; color: white; text-align:left;"
|colspan="6" width="25%"| Gegevenselement
|| Waarde
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="6"|Identificatie
|style="background-color: white;"|MBH_MO_123_4_MA_1 (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1)
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="6"|Afspraakdatum
|style="background-color: white;"|T- 60 dagen, om 09:13
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="6"|Gebruiksperiode
|style="background-color: white;"|Vanaf T- 60 dagen, tot nader order
|-style="vertical-align:top; background-color: #E3E3E3;;" 
|colspan="7"|Voorschrijver
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="10"|
|-style="vertical-align:top; background-color: #E3E3E3;;" 
|colspan="6"|Zorgverlener
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="8"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Naamgegevens
|style="background-color: white;"|I. Ternist
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Specialisme
|style="background-color: white;"|Medisch specialisten, inwendige geneeskunde (code = '0313' in codeSystem 'COD016-VEKT (Vektis Zorgverlenersspecificatie (subberoepsgroep))')
|-style="vertical-align:top; background-color: #E3E3E3;;" 
|colspan="5"|Zorgaanbieder
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="4"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Zorgaanbieder identificatienummer
|style="background-color: white;"|00001113 (in identificerend systeem: URA)
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Organisatie naam
|style="background-color: white;"|Antonius
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Adresgegevens
|style="background-color: white;"|Werkadres: Dorpsstraat 1 1234AA Ons Dorp
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="6"|Geneesmiddel - primaire code
|style="background-color: white;"|INSULINE GLARGINE INJVLST 100E/ML (code = '121312' in codeSystem 'G-Standaard PRK')
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="6"|Geneesmiddel - generiekere code
|style="background-color: white;"|INSULINE GLARGINE INJVLST 100E/ML (code = '128651' in codeSystem 'G-Standaard GPK')
|-style="vertical-align:top; background-color: #E3E3E3;;" 
|colspan="7"|Gebruiksinstructie
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="4"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="5"|Omschrijving
|style="background-color: white;"|Vanaf T- 60 dagen, tot nader order, 1 maal per dag 10IE, SUBCUTAAN
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="5"|Toedieningsweg
|style="background-color: white;"|subcutaan (code = '21' in codeSystem 'G-Standaard Toedieningswegen (tabel 7)')
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="5"|Doseerinstructie
|style="background-color: white;"|1 maal per dag 10 internationale eenheid
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="6"|Kopie indicator
|style="background-color: white;"|Ja
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="6"|MBH identificatie
|style="background-color: white;"|MBH_MO_123_4 (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1)
|}
{| class="wikitable" width="85%"
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;"  colspan="6" | Toedieningsafspraak
|-style="background-color: #1F497D;; color: white; text-align:left;"
|colspan="5" width="25%"| Gegevenselement
|| Waarde
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="5"|Identificatie
|style="background-color: white;"|MBH_MO_123_4_TA_1 (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.422037009.1)
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="5"|Afspraakdatum
|style="background-color: white;"|T- 60 dagen, om 15:55
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="5"|Gebruiksperiode
|style="background-color: white;"|Vanaf T- 60 dagen, tot nader order
|-style="vertical-align:top; background-color: #E3E3E3;;" 
|colspan="6"|Verstrekker
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="5"|
|-style="vertical-align:top; background-color: #E3E3E3;;" 
|colspan="5"|Zorgaanbieder
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="3"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Zorgaanbieder identificatie nummer
|style="background-color: white;"|13336578 (in identificerend systeem: URA)
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Organisatie naam
|style="background-color: white;"|Poliapotheek Antonius
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="5"|Geneesmiddel - primaire code
|style="background-color: white;"|LANTUS SOLOSTAR INJ 100E/ML PEN 3ML (code = '1859226' in codeSystem 'G-Standaard HPK')
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="5"|Geneesmiddel - generiekere code
|style="background-color: white;"|INSULINE GLARGINE INJVLST 100E/ML (code = '121312' in codeSystem 'G-Standaard PRK')
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="5"|Geneesmiddel - generiekere code
|style="background-color: white;"|INSULINE GLARGINE INJVLST 100E/ML (code = '128651' in codeSystem 'G-Standaard GPK')
|-style="vertical-align:top; background-color: #E3E3E3;;" 
|colspan="6"|Gebruiksinstructie
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="4"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Omschrijving
|style="background-color: white;"|Vanaf T- 60 dagen, tot nader order, Elke dag om 9 uur 10IE, subcutaan
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Toedieningsweg
|style="background-color: white;"|subcutaan (code = '21' in codeSystem 'G-Standaard Toedieningswegen (tabel 7)')
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Doseerinstructie
|style="background-color: white;"|elke dag om 10 internationale eenheid
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="5"|Kopie indicator
|style="background-color: white;"|Ja
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="5"|Relatie naar medicatieafspraak
|style="background-color: white;"|MBH_MO_123_4_MA_1
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="5"|MBH identificatie
|style="background-color: white;"|MBH_MO_123_4 (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1)
|}<section end=MBH_MBH_MO_123_4 /><section begin=MBH_MBH_MO_123_5 />
====Medicamenteuze behandeling MBH_MO_123_5 ====
 
{| class="wikitable" width="85%"
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;"  colspan="6" | Toedieningsafspraak
|-style="background-color: #1F497D;; color: white; text-align:left;"
|colspan="5" width="25%"| Gegevenselement
|| Waarde
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="5"|Identificatie
|style="background-color: white;"|MBH_MO_123_5_TA_1 (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.422037009.1)
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="5"|Afspraakdatum
|style="background-color: white;"|T- 36 dagen, om 15:55
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="5"|Gebruiksperiode
|style="background-color: white;"|Vanaf T- 36 dagen, gedurende 90 dagen
|-style="vertical-align:top; background-color: #E3E3E3;;" 
|colspan="6"|Verstrekker
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="5"|
|-style="vertical-align:top; background-color: #E3E3E3;;" 
|colspan="5"|Zorgaanbieder
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="3"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Zorgaanbieder identificatie nummer
|style="background-color: white;"|13336578 (in identificerend systeem: URA)
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Organisatie naam
|style="background-color: white;"|Poliapotheek Antonius
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="5"|Geneesmiddel - primaire code
|style="background-color: white;"|PERINDOPRIL TERT-BUTYLAMINE GLENMARK TABLET 8MG (code = '2105594' in codeSystem 'G-Standaard HPK')
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="5"|Geneesmiddel - generiekere code
|style="background-color: white;"|PERINDOPRIL TABLET 8MG (ERBUMINE) (code = '69523' in codeSystem 'G-Standaard PRK')
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="5"|Geneesmiddel - generiekere code
|style="background-color: white;"|PERINDOPRIL TABLET 8MG (ERBUMINE) (code = '117722' in codeSystem 'G-Standaard GPK')
|-style="vertical-align:top; background-color: #E3E3E3;;" 
|colspan="6"|Gebruiksinstructie
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="4"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Omschrijving
|style="background-color: white;"|Vanaf T- 36 dagen, gedurende 90 dagen, 1 maal per dag 1 tablet, oraal
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Toedieningsweg
|style="background-color: white;"|oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen (tabel 7)')
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Doseerinstructie
|style="background-color: white;"|1 maal per dag 1 stuk
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="5"|Kopie indicator
|style="background-color: white;"|Ja
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="5"|MBH identificatie
|style="background-color: white;"|MBH_MO_123_5 (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1)
|}
{| class="wikitable" width="85%"
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;"  colspan="5" | Medicatie gebruik
|-style="background-color: #1F497D;; color: white; text-align:left;"
|colspan="4" width="25%"| Gegevenselement
|| Waarde
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Identificatie
|style="background-color: white;"|MBH_MO_123_5_MGB_1 (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.6.1)
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Registratiedatum
|style="background-color: white;"|T- 33 dagen, om 13:58
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Gebruik indicator
|style="background-color: white;"|Nee
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Volgens afspraak indicator
|style="background-color: white;"|Nee
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Gebruiksperiode
|style="background-color: white;"|Vanaf T- 34 dagen, tot nader order
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Stoptype
|style="background-color: white;"|Staking (code = '2' in codeSystem '2.16.840.1.113883.2.4.3.11.60.20.77.5.2.1')
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Geneesmiddel - primaire code
|style="background-color: white;"|PERINDOPRIL TERT-BUTYLAMINE GLENMARK TABLET 8MG (code = '2105594' in codeSystem 'G-Standaard HPK')
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Geneesmiddel - generiekere code
|style="background-color: white;"|PERINDOPRIL TABLET 8MG (ERBUMINE) (code = '69523' in codeSystem 'G-Standaard PRK')
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Geneesmiddel - generiekere code
|style="background-color: white;"|PERINDOPRIL TABLET 8MG (ERBUMINE) (code = '117722' in codeSystem 'G-Standaard GPK')
|-style="vertical-align:top; background-color: #E3E3E3;;" 
|colspan="5"|Gebruiksinstructie
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="2"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Omschrijving
|style="background-color: white;"|Vanaf T- 34 dagen, tot nader order, gestaakt
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Gerelateerde afspraak : TA
|style="background-color: white;"|MBH_MO_123_5_TA_1
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Auteur
|style="background-color: white;"|Patiënt
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Reden wijzigen of stoppen gebruik
|style="background-color: white;"|Te sterk effect (code = '6' in codeSystem '2.16.840.1.113883.2.4.3.11.60.20.77.5.2.2')
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Kopie indicator
|style="background-color: white;"|Ja
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Toelichting
|style="background-color: white;"|Gestopt vanwege bijwerkingen
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|MBH identificatie
|style="background-color: white;"|MBH_MO_123_5 (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1)
|}<section end=MBH_MBH_MO_123_5 /><section begin=MBH_MBH_MO_123_6 />
====Medicamenteuze behandeling MBH_MO_123_6 ====
 
{| class="wikitable" width="85%"
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;"  colspan="7" | Medicatieafspraak
|-style="background-color: #1F497D;; color: white; text-align:left;"
|colspan="6" width="25%"| Gegevenselement
|| Waarde
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="6"|Identificatie
|style="background-color: white;"|MBH_MO_123_6_MA_1 (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1)
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="6"|Afspraakdatum
|style="background-color: white;"|T- 728 dagen, om 09:13
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="6"|Gebruiksperiode
|style="background-color: white;"|Vanaf T- 728 dagen, tot nader order
|-style="vertical-align:top; background-color: #E3E3E3;;" 
|colspan="7"|Voorschrijver
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="10"|
|-style="vertical-align:top; background-color: #E3E3E3;;" 
|colspan="6"|Zorgverlener
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="8"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Naamgegevens
|style="background-color: white;"|John de  Vries
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Specialisme
|style="background-color: white;"|Huisartsen, niet nader gespecificeerd (code = '0100' in codeSystem 'COD016-VEKT (Vektis Zorgverlenersspecificatie (subberoepsgroep))')
|-style="vertical-align:top; background-color: #E3E3E3;;" 
|colspan="5"|Zorgaanbieder
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="4"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Zorgaanbieder identificatienummer
|style="background-color: white;"|00001111 (in identificerend systeem: URA)
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Organisatie naam
|style="background-color: white;"|Huisartsenpraktijk Pulver & Partners
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Adresgegevens
|style="background-color: white;"|Werkadres: Dorpsstraat 1 1234AA Ons Dorp
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="6"|Geneesmiddel - primaire code
|style="background-color: white;"|Simvastine tablet fo 20 mg (code = '67814' in codeSystem 'G-Standaard PRK')
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="6"|Geneesmiddel - generiekere code
|style="background-color: white;"|Simvastine tablet fo 20 mg (code = '116580' in codeSystem 'G-Standaard GPK')
|-style="vertical-align:top; background-color: #E3E3E3;;" 
|colspan="7"|Gebruiksinstructie
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="4"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="5"|Omschrijving
|style="background-color: white;"|Vanaf T- 728 dagen, tot nader order, 1 maal per dag 1 tablet 's avonds, oraal
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="5"|Toedieningsweg
|style="background-color: white;"|oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen (tabel 7)')
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="5"|Doseerinstructie
|style="background-color: white;"|1 maal per dag 1 stuk 's avonds
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="6"|Kopie indicator
|style="background-color: white;"|Ja
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="6"|MBH identificatie
|style="background-color: white;"|MBH_MO_123_6 (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1)
|}
{| class="wikitable" width="85%"
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;"  colspan="6" | Toedieningsafspraak
|-style="background-color: #1F497D;; color: white; text-align:left;"
|colspan="5" width="25%"| Gegevenselement
|| Waarde
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="5"|Identificatie
|style="background-color: white;"|MBH_MO_123_6_TA_1 (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.422037009.1)
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="5"|Afspraakdatum
|style="background-color: white;"|T- 323 dagen, om 15:55
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="5"|Gebruiksperiode
|style="background-color: white;"|Vanaf T- 323 dagen, tot nader order
|-style="vertical-align:top; background-color: #E3E3E3;;" 
|colspan="6"|Verstrekker
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="5"|
|-style="vertical-align:top; background-color: #E3E3E3;;" 
|colspan="5"|Zorgaanbieder
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="3"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Zorgaanbieder identificatie nummer
|style="background-color: white;"|13336578 (in identificerend systeem: URA)
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Organisatie naam
|style="background-color: white;"|Poliapotheek Antonius
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="5"|Geneesmiddel - primaire code
|style="background-color: white;"|SIMVASTATINE APOTEX TABLET FILMOMHULD 10MG (code = '1537792' in codeSystem 'G-Standaard HPK')
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="5"|Geneesmiddel - generiekere code
|style="background-color: white;"|Simvastine tablet fo 20 mg (code = '67814' in codeSystem 'G-Standaard PRK')
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="5"|Geneesmiddel - generiekere code
|style="background-color: white;"|Simvastine tablet fo 20 mg (code = '116580' in codeSystem 'G-Standaard GPK')
|-style="vertical-align:top; background-color: #E3E3E3;;" 
|colspan="6"|Gebruiksinstructie
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="4"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Omschrijving
|style="background-color: white;"|Vanaf T- 323 dagen, tot nader order, 1 maal per dag 2 tabletten 's avonds, oraal
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Toedieningsweg
|style="background-color: white;"|oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen (tabel 7)')
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Doseerinstructie
|style="background-color: white;"|1 maal per dag 2 stuks 's avonds
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="5"|Kopie indicator
|style="background-color: white;"|Ja
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="5"|Relatie naar medicatieafspraak
|style="background-color: white;"|MBH_MO_123_6_MA_1
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="5"|MBH identificatie
|style="background-color: white;"|MBH_MO_123_6 (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1)
|}
{| class="wikitable" width="85%"
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;"  colspan="5" | Medicatie gebruik
|-style="background-color: #1F497D;; color: white; text-align:left;"
|colspan="4" width="25%"| Gegevenselement
|| Waarde
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Identificatie
|style="background-color: white;"|MBH_MO_123_6_MGB_1 (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.6.1)
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Registratiedatum
|style="background-color: white;"|T- 248 dagen, om 09:00
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Gebruik indicator
|style="background-color: white;"|Ja
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Volgens afspraak indicator
|style="background-color: white;"|Nee
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Gebruiksperiode
|style="background-color: white;"|Vanaf T- 248 dagen, tot nader order
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Geneesmiddel - primaire code
|style="background-color: white;"|SIMVASTATINE APOTEX TABLET FILMOMHULD 10MG (code = '1537792' in codeSystem 'G-Standaard HPK')
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Geneesmiddel - generiekere code
|style="background-color: white;"|Simvastine tablet fo 20 mg (code = '67814' in codeSystem 'G-Standaard PRK')
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Geneesmiddel - generiekere code
|style="background-color: white;"|Simvastine tablet fo 20 mg (code = '116580' in codeSystem 'G-Standaard GPK')
|-style="vertical-align:top; background-color: #E3E3E3;;" 
|colspan="5"|Gebruiksinstructie
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="4"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Omschrijving
|style="background-color: white;"|Vanaf T- 248 dagen, tot nader order, 1 maal per dag 1 tablet 's avonds, oraal
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Toedieningsweg
|style="background-color: white;"|oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen (tabel 7)')
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Doseerinstructie
|style="background-color: white;"|1 maal per dag 1 stuk 's avonds
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Auteur
|style="background-color: white;"|Zorgverlener  :  I. Ternist  - Medisch specialisten, inwendige geneeskunde.  Antonius
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Kopie indicator
|style="background-color: white;"|Nee
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Toelichting
|style="background-color: white;"|Patiënt gebruikt niet volgens voorschrift
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|MBH identificatie
|style="background-color: white;"|MBH_MO_123_6 (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1)
|}
{| class="wikitable" width="85%"
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;"  colspan="5" | Medicatie gebruik
|-style="background-color: #1F497D;; color: white; text-align:left;"
|colspan="4" width="25%"| Gegevenselement
|| Waarde
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Identificatie
|style="background-color: white;"|MBH_MO_123_6_MGB_2 (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.6.1)
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Registratiedatum
|style="background-color: white;"|T- 172 dagen, om 15:37
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Gebruik indicator
|style="background-color: white;"|Ja
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Volgens afspraak indicator
|style="background-color: white;"|Nee
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Gebruiksperiode
|style="background-color: white;"|Vanaf T- 248 dagen, tot en met T- 173 dagen, om 23:59
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Geneesmiddel - primaire code
|style="background-color: white;"|SIMVASTATINE APOTEX TABLET FILMOMHULD 10MG (code = '1537792' in codeSystem 'G-Standaard HPK')
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Geneesmiddel - generiekere code
|style="background-color: white;"|Simvastine tablet fo 20 mg (code = '67814' in codeSystem 'G-Standaard PRK')
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Geneesmiddel - generiekere code
|style="background-color: white;"|Simvastine tablet fo 20 mg (code = '116580' in codeSystem 'G-Standaard GPK')
|-style="vertical-align:top; background-color: #E3E3E3;;" 
|colspan="5"|Gebruiksinstructie
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="4"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Omschrijving
|style="background-color: white;"|Vanaf T- 248 dagen, tot en met T- 173 dagen, om 23:59, 1 maal per dag 1 tablet 's avonds, oraal, gestopt
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Toedieningsweg
|style="background-color: white;"|oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen (tabel 7)')
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Doseerinstructie
|style="background-color: white;"|1 maal per dag 1 stuk 's avonds
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Gerelateerde afspraak : MA
|style="background-color: white;"|MBH_MO_123_6_MA_1
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Auteur
|style="background-color: white;"|Patiënt
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Toelichting
|style="background-color: white;"|Veel last van jeuk
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|MBH identificatie
|style="background-color: white;"|MBH_MO_123_6 (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1)
|}<section end=MBH_MBH_MO_123_6 /><section begin=MBH_MBH_MO_123_7 />
====Medicamenteuze behandeling MBH_MO_123_7 ====
 
{| class="wikitable" width="85%"
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;"  colspan="7" | Medicatieafspraak
|-style="background-color: #1F497D;; color: white; text-align:left;"
|colspan="6" width="25%"| Gegevenselement
|| Waarde
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="6"|Identificatie
|style="background-color: white;"|MBH_MO_123_7_MA_1 (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1)
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="6"|Afspraakdatum
|style="background-color: white;"|T+ 3 dagen, om 09:27
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="6"|Gebruiksperiode
|style="background-color: white;"|Vanaf T+ 3 dagen, tot en met T+ 17 dagen, om 23:59
|-style="vertical-align:top; background-color: #E3E3E3;;" 
|colspan="7"|Voorschrijver
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="10"|
|-style="vertical-align:top; background-color: #E3E3E3;;" 
|colspan="6"|Zorgverlener
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="8"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Naamgegevens
|style="background-color: white;"|John de  Vries
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Specialisme
|style="background-color: white;"|Huisartsen, niet nader gespecificeerd (code = '0100' in codeSystem 'COD016-VEKT (Vektis Zorgverlenersspecificatie (subberoepsgroep))')
|-style="vertical-align:top; background-color: #E3E3E3;;" 
|colspan="5"|Zorgaanbieder
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="4"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Zorgaanbieder identificatienummer
|style="background-color: white;"|00001111 (in identificerend systeem: URA)
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Organisatie naam
|style="background-color: white;"|Huisartsenpraktijk Pulver & Partners
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Adresgegevens
|style="background-color: white;"|Werkadres: Dorpsstraat 1 1234AA Ons Dorp
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="6"|Geneesmiddel - primaire code
|style="background-color: white;"|Flucloxacilline capsule 500mg (code = '5274' in codeSystem 'G-Standaard PRK')
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="6"|Geneesmiddel - generiekere code
|style="background-color: white;"|Flucloxacilline capsule 500mg (code = '15466' in codeSystem 'G-Standaard GPK')
|-style="vertical-align:top; background-color: #E3E3E3;;" 
|colspan="7"|Gebruiksinstructie
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="4"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="5"|Omschrijving
|style="background-color: white;"|Vanaf T+ 3 dagen, tot en met T+ 17 dagen, om 23:59, Elke 8 uur 1 capsule, oraal
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="5"|Toedieningsweg
|style="background-color: white;"|oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen (tabel 7)')
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="5"|Doseerinstructie
|style="background-color: white;"|1 maal per dag 1 stuk
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="6"|Kopie indicator
|style="background-color: white;"|Ja
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="6"|MBH identificatie
|style="background-color: white;"|MBH_MO_123_7 (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1)
|}<section end=MBH_MBH_MO_123_7 /><section begin=MBH_MBH_MO_123_8 />
====Medicamenteuze behandeling MBH_MO_123_8 ====
 
{| class="wikitable" width="85%"
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;"  colspan="6" | Toedieningsafspraak
|-style="background-color: #1F497D;; color: white; text-align:left;"
|colspan="5" width="25%"| Gegevenselement
|| Waarde
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="5"|Identificatie
|style="background-color: white;"|MBH_MO_123_8_TA_2 (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.422037009.1)
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="5"|Afspraakdatum
|style="background-color: white;"|T- 28 dagen, om 11:50
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="5"|Gebruiksperiode
|style="background-color: white;"|Vanaf T- 45 dagen, tot en met T- 29 dagen, om 23:59
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="5"|Stoptype
|style="background-color: white;"|Onderbreking (code = '1' in codeSystem '2.16.840.1.113883.2.4.3.11.60.20.77.5.2.1')
|-style="vertical-align:top; background-color: #E3E3E3;;" 
|colspan="6"|Verstrekker
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="5"|
|-style="vertical-align:top; background-color: #E3E3E3;;" 
|colspan="5"|Zorgaanbieder
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="3"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Zorgaanbieder identificatie nummer
|style="background-color: white;"|13336578 (in identificerend systeem: URA)
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Organisatie naam
|style="background-color: white;"|Poliapotheek Antonius
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="5"|Reden afspraak
|style="background-color: white;"|Beleidswijziging
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="5"|Geneesmiddel - primaire code
|style="background-color: white;"|Atorvastatine ranbaxy tablet filmomhuld 40 mg (code = '2230879' in codeSystem 'G-Standaard HPK')
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="5"|Geneesmiddel - generiekere code
|style="background-color: white;"|ATORVASTATINE TABLET 40MG (ALS CA-ZOUT-3-WATER) (code = '98620' in codeSystem 'G-Standaard PRK')
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="5"|Geneesmiddel - generiekere code
|style="background-color: white;"|ATORVASTATINE TABLET 40MG (ALS CA-ZOUT-3-WATER) (code = '137219' in codeSystem 'G-Standaard GPK')
|-style="vertical-align:top; background-color: #E3E3E3;;" 
|colspan="6"|Gebruiksinstructie
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="4"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Omschrijving
|style="background-color: white;"|Vanaf T- 45 dagen, tot en met T- 29 dagen, om 23:59, 1 maal per dag 2 tabletten 's avonds, oraal
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Toedieningsweg
|style="background-color: white;"|oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen (tabel 7)')
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Doseerinstructie
|style="background-color: white;"|1 maal per dag 2 stuks 's avonds
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="5"|Kopie indicator
|style="background-color: white;"|Ja
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="5"|Relatie naar medicatieafspraak
|style="background-color: white;"|MBH_MO_123_8_MA_3
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="5"|MBH identificatie
|style="background-color: white;"|MBH_MO_123_8 (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1)
|}<section end=MBH_MBH_MO_123_8 /><section begin=MBH_MBH_MO_123_9 />
====Medicamenteuze behandeling MBH_MO_123_9 ====
 
{| class="wikitable" width="85%"
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;"  colspan="7" | Medicatieafspraak
|-style="background-color: #1F497D;; color: white; text-align:left;"
|colspan="6" width="25%"| Gegevenselement
|| Waarde
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="6"|Identificatie
|style="background-color: white;"|MBH_MO_123_9_MA_1 (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1)
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="6"|Afspraakdatum
|style="background-color: white;"|T- 45 dagen, om 11:50
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="6"|Gebruiksperiode
|style="background-color: white;"|Vanaf T- 45 dagen, tot en met T- 31 dagen, om 23:59
|-style="vertical-align:top; background-color: #E3E3E3;;" 
|colspan="7"|Voorschrijver
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="10"|
|-style="vertical-align:top; background-color: #E3E3E3;;" 
|colspan="6"|Zorgverlener
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="8"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Naamgegevens
|style="background-color: white;"|John de  Vries
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Specialisme
|style="background-color: white;"|Huisartsen, niet nader gespecificeerd (code = '0100' in codeSystem 'COD016-VEKT (Vektis Zorgverlenersspecificatie (subberoepsgroep))')
|-style="vertical-align:top; background-color: #E3E3E3;;" 
|colspan="5"|Zorgaanbieder
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="4"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Zorgaanbieder identificatienummer
|style="background-color: white;"|00001111 (in identificerend systeem: URA)
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Organisatie naam
|style="background-color: white;"|Huisartsenpraktijk Pulver & Partners
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Adresgegevens
|style="background-color: white;"|Werkadres: Dorpsstraat 1 1234AA Ons Dorp
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="6"|Geneesmiddel - primaire code
|style="background-color: white;"|FLUCLOXACILLINE CAPSULE 500MG (code = '5274' in codeSystem 'G-Standaard PRK')
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="6"|Geneesmiddel - generiekere code
|style="background-color: white;"|FLUCLOXACILLINE CAPSULE 500MG (code = '15466' in codeSystem 'G-Standaard GPK')
|-style="vertical-align:top; background-color: #E3E3E3;;" 
|colspan="7"|Gebruiksinstructie
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="4"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="5"|Omschrijving
|style="background-color: white;"|Vanaf T- 45 dagen, tot en met T- 31 dagen, om 23:59, 1 keer per exact 8 uur 1 stuk, oraal
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="5"|Toedieningsweg
|style="background-color: white;"|oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen (tabel 7)')
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="5"|Doseerinstructie
|style="background-color: white;"|exact iedere 8 uur 1 stuk
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="6"|Kopie indicator
|style="background-color: white;"|Ja
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="6"|MBH identificatie
|style="background-color: white;"|MBH_MO_123_9 (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1)
|}<section end=MBH_MBH_MO_123_9 /><section begin=MBH_MBH_MO_123_10 />
====Medicamenteuze behandeling MBH_MO_123_10 ====
 
{| class="wikitable" width="85%"
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;"  colspan="6" | Toedieningsafspraak
|-style="background-color: #1F497D;; color: white; text-align:left;"
|colspan="5" width="25%"| Gegevenselement
|| Waarde
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="5"|Identificatie
|style="background-color: white;"|MBH_MO_123_10_TA_2 (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.422037009.1)
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="5"|Afspraakdatum
|style="background-color: white;"|T- 36 dagen, om 15:50
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="5"|Gebruiksperiode
|style="background-color: white;"|Vanaf T- 56 dagen, tot en met T- 37 dagen, om 23:59
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="5"|Stoptype
|style="background-color: white;"|Staking (code = '2' in codeSystem '2.16.840.1.113883.2.4.3.11.60.20.77.5.2.1')
|-style="vertical-align:top; background-color: #E3E3E3;;" 
|colspan="6"|Verstrekker
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="5"|
|-style="vertical-align:top; background-color: #E3E3E3;;" 
|colspan="5"|Zorgaanbieder
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="3"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Zorgaanbieder identificatie nummer
|style="background-color: white;"|13336578 (in identificerend systeem: URA)
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Organisatie naam
|style="background-color: white;"|Poliapotheek Antonius
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="5"|Reden afspraak
|style="background-color: white;"|Geen of onvoldoende effect
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="5"|Geneesmiddel - primaire code
|style="background-color: white;"|PERINDOPRIL TERT-BUTYLAMINE GLENMARK TABLET 4MG (code = '2105586' in codeSystem 'G-Standaard HPK')
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="5"|Geneesmiddel - generiekere code
|style="background-color: white;"|PERINDOPRIL TABLET 4MG (ERBUMINE) (code = '29076' in codeSystem 'G-Standaard PRK')
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="5"|Geneesmiddel - generiekere code
|style="background-color: white;"|PERINDOPRIL TABLET 4MG (ERBUMINE) (code = '75434' in codeSystem 'G-Standaard GPK')
|-style="vertical-align:top; background-color: #E3E3E3;;" 
|colspan="6"|Gebruiksinstructie
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="4"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Omschrijving
|style="background-color: white;"|Vanaf T- 56 dagen, tot en met T- 37 dagen, om 23:59, 1 maal per dag 1 tablet 's morgens, oraal
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Toedieningsweg
|style="background-color: white;"|oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen (tabel 7)')
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Doseerinstructie
|style="background-color: white;"|1 maal per dag 1 stuk 's ochtends
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="5"|Kopie indicator
|style="background-color: white;"|Ja
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="5"|MBH identificatie
|style="background-color: white;"|MBH_MO_123_10 (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1)
|}<section end=MBH_MBH_MO_123_10 /><section end=MBHS_XXX_Jangi />
===Versiehistorie===
<section begin=versiehistorie />       
{| class="wikitable" width="85%"
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;"  colspan="2" | Versiegegevens
|-style="background-color: #1F497D;; color: white; text-align:left;"
|colspan="1" width="25%"| Datum
|| Beschrijving
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="1"|26 aug 2019
|style="background-color: white;"|[https://bits.nictiz.nl/browse/MM-477 Issue MM-477] - adressoort toegevoegd bij alle adressen
|}
|}
<section end=versiehistorie />
 
[[Categorie:Kwalificatie]]

Huidige versie van 30 sep 2022 om 13:40

Tabel 1. Overzicht situaties specifieke en generieke MBH-id voor EVS en AIS
Situatie EVS AIS ETDR
Migreren van actuele en recent gestopte medicatie Specifieke MBH-id Generieke MBH-id Generieke MBH-id
Migreren van historische medicatie Generieke MBH-id Generieke MBH-id Generieke MBH-id
Starten van nieuwe MBH Specieke MBH-id Generieke MBH-id[1] Generieke MBH-id
  1. ↑ AIS initieert in principe géén specifieke MBH-id. Alleen wanneer er geen PRK is, maakt het AIS een specifieke MBH-id aan (zie paragraaf Bijzondere situaties).
Overgenomen van "https://informatiestandaarden.test-nictiz.nl/index.php?title=mp:Vdraft_Sandbox&oldid=137150"